BDNF and neoplasm: In addition to direct regulation of neural development, the Wnt pathway may be modified epigenetically, as the tumour-suppressing miR-137 can simultaneously modulate Akt pathway activity (Thomas et al., 2017) and the expression of brain-derived neurotrophic factor (Hill et al., 2014), highlighting its dual effects on tumour growth and SCZ risk.